Malignant pleural mesothelioma (MPM ... as the radiosensitivity of malignant mesothelial cells is modest. MPM response to chemotherapy is comparatively poor. The combination of pemetrexed and ...

Chemotherapy with pemetrexed and cisplatin (or carboplatin) has become the preferred first-line treatment of malignant pleural mesothelioma based on a randomized Phase III study. Vinorelbine has ...

Institute of Pathology, Statistics and Documentation, Medical University of Graz, Austria Background: Malignant pleural mesothelioma (MPM ... Asbestos causes genetic modifications and cell signalling ...

Human MSCs transduced with a lentiviral vector encoding TRAIL were shown in vitro to kill multiple malignant mesothelioma cell lines as predicted by sensitivity to recombinant TRAIL (rTRAIL). In vivo ...

This Review focuses on recent observations on the role of radiotherapy in the treatment of malignant pleural mesothelioma ... Looking at human mesothelioma cell lines, we observed that their ...

Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...

Objectives Malignant mesothelioma is an uncommon cancer associated with asbestos exposure, predominantly occupational. Asbestos has been banned in Australia since 2003 but mesothelioma has a long ...